iSpecimen Statistics
Share Statistics
iSpecimen has 2.5M
shares outstanding. The number of shares has increased by -92.64%
in one year.
| Shares Outstanding | 2.5M |
| Shares Change (YoY) | -92.64% |
| Shares Change (QoQ) | 0% |
| Owned by Institutions (%) | 3.5% |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 1,308 |
| FTD / Avg. Volume | 0.25% |
Short Selling Information
The latest short interest is 57.81K, so 2.32% of the outstanding
shares have been sold short.
| Short Interest | 57.81K |
| Short % of Shares Out | 2.32% |
| Short % of Float | 2.32% |
| Short Ratio (days to cover) | 1 |
Valuation Ratios
The PE ratio is -0.15 and the forward
PE ratio is null.
iSpecimen's PEG ratio is
0.
| PE Ratio | -0.15 |
| Forward PE | n/a |
| PS Ratio | 0.2 |
| Forward PS | 0.1 |
| PB Ratio | 0.57 |
| P/FCF Ratio | -0.23 |
| PEG Ratio | 0 |
Financial Ratio HistoryEnterprise Valuation
Currently the Enterprise Value (EV) is not available for iSpecimen.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.62,
with a Debt / Equity ratio of 0.09.
| Current Ratio | 0.62 |
| Quick Ratio | 0.62 |
| Debt / Equity | 0.09 |
| Debt / EBITDA | -0.02 |
| Debt / FCF | -0.04 |
| Interest Coverage | -57.84 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $387,129.79 |
| Profits Per Employee | $-520,741.88 |
| Employee Count | 24 |
| Asset Turnover | 0.99 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by -76.36% in the
last 52 weeks. The beta is 1.77, so iSpecimen's
price volatility has been higher than the market average.
| Beta | 1.77 |
| 52-Week Price Change | -76.36% |
| 50-Day Moving Average | 1.36 |
| 200-Day Moving Average | 3.49 |
| Relative Strength Index (RSI) | 49.76 |
| Average Volume (20 Days) | 525,129 |
Income Statement
In the last 12 months, iSpecimen had revenue of 9.29M
and earned -12.5M
in profits. Earnings per share was -17.58.
| Revenue | 9.29M |
| Gross Profit | 3.99M |
| Operating Income | -12.73M |
| Net Income | -12.5M |
| EBITDA | -12.73M |
| EBIT | -12.67M |
| Earnings Per Share (EPS) | -17.58 |
Full Income StatementBalance Sheet
The company has 1.88M in cash and 312.17K in
debt, giving a net cash position of 1.57M.
| Cash & Cash Equivalents | 1.88M |
| Total Debt | 312.17K |
| Net Cash | 1.57M |
| Retained Earnings | -71.86M |
| Total Assets | 9.35M |
| Working Capital | -2.18M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -8.26M
and capital expenditures -31.55K, giving a free cash flow of -8.3M.
| Operating Cash Flow | -8.26M |
| Capital Expenditures | -31.55K |
| Free Cash Flow | -8.3M |
| FCF Per Share | -11.67 |
Full Cash Flow StatementMargins
Gross margin is 42.93%, with operating and profit margins of -136.99% and -134.51%.
| Gross Margin | 42.93% |
| Operating Margin | -136.99% |
| Pretax Margin | -134.51% |
| Profit Margin | -134.51% |
| EBITDA Margin | -136.99% |
| EBIT Margin | -136.99% |
| FCF Margin | -89.28% |
